Return to Main Library
HYPERCHOLESTEROLEMIA
See also our webinar on Nutritional Considerations of Cardiovascular Disease
2010 J Pediatr
Rosuvastatin Lowers Coenzyme Q10 Levels, but not Mitochondrial Adenosine Triphosphate Synthesis, in Children with Familial Hypercholesterolemia.
2009 Am J Clin Nutr
L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
2009 Atherosclerosis
High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis.
2009 Biochim Biophys Acta
Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol.
2009 Br J Nutr
Effects of magnesium on postprandial serum lipid responses in healthy human subjects.
2008 Cardiovasc J Afr
Effect of calcium lactate supplementation on cholesterol concentration in patients with hyperlipidaemia and previous viral hepatitis: a preliminary report.
2008 J Clin Lipidol
Plasma coenzyme Q10 predicts lipid-lowering response to high-dose atorvastatin.
FREE FULL TEXT
2008 J Nutr Sci Vitaminol
Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.
FREE FULL TEXT
2007 Am J Clin Nutr
Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients
2007 Int J Cardiol
Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
2006 Pediatrics
Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-Up Study.
FREE FULL TEXT
2005 Am J Med Sci
Adressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States
2005 Am J Med Sci
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
2005 The Standard
Managing lipoprotein dyslipidemias through lifestyle and nutraceutical therapies
FREE FULL TEXT
2004 Circulation
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
FREE FULL TEXT
2000 Am J Clin Nutr
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
FREE FULL TEXT
1998 Arch Intern Med
Maximizing the cost-effectiveness of lipid-lowering therapy.
FREE FULL TEXT
1995 Lipids
Response of hypercholesterolemic subjects to administration of tocotrienols
back to top
